Xeris Biopharma Holdings, Inc. Quarterly Operating Margin in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Xeris Biopharma Holdings, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q3 2024.
  • Xeris Biopharma Holdings, Inc. Operating Margin for the quarter ending September 30, 2024 was -24.1 %, a 25.4% increase year-over-year.
  • Xeris Biopharma Holdings, Inc. annual Operating Margin for 2021 was -232 %, a 43.2% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -24.1 +8.21 +25.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -20.5 +26.6 +56.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -26.3 +28.3 +51.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -26.9 +47.5 +63.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -32.3 +84.3 +72.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -47.1 +104 +68.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -54.5 +146 +72.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -74.3 +158 +68% Oct 1, 2022 Dec 31, 2022
Q3 2022 -117 Jul 1, 2022 Sep 30, 2022
Q2 2022 -151 Apr 1, 2022 Jun 30, 2022
Q1 2022 -200 Jan 1, 2022 Mar 31, 2022
Q4 2021 -232 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.